THE MIDOSTAURIN DIARIES

Rydapt has long been revealed to further improve survival in patients with AML related to an FLT3 mutation. 1 main study, involving 717 this sort of individuals, in contrast Rydapt with placebo (a dummy therapy) to begin with being an addition to other cancer medicines, followed by procedure with Rydapt or placebo by yourself in All those whose dis